United States Biotechnology & Medical Research

AIM ImmunoTech Inc (AIM)

Track

Recent insider activity shows a series of buy transactions, primarily by CEO Thomas K. Equels, with the most recent occurring on June 13, 2025. Significant purchases were also made by other insiders in April 2025. A notable sell transaction by William M. Mitchell occurred in December 2024.
Stock chart
Ticker: AIM Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Equels Thomas K
CEO & President
1 purchase — total 824 USD
Buy 13 Jun 2025
Value US$3,170,510.77 | Price 146.17 | Shares 14,818
Buy 12 Jun 2025
Value US$2,193,444.32 | Price 439.40 | Shares 19,701
Buy 11 Apr 2025
Value US$50,000.00 | Price 0.03 | Shares 1,968,504
Buy 11 Apr 2025
Value US$5,000.02 | Price 0.03 | Shares 196,851
Buy 11 Apr 2025
Value US$50,000.00 | Price 0.03 | Shares 1,968,504
Buy 4 Apr 2025
Value US$2,583.00 | Price 0.06 | Shares 41,000
Buy 4 Apr 2025
Value US$43.50 | Price 0.09 | Shares 500
Buy 5 Mar 2025
Value US$6,730.00 | Price 0.13 | Shares 50,000
Buy 4 Mar 2025
Value US$5,060.00 | Price 0.12 | Shares 44,000
Buy 4 Mar 2025
Value US$10,000.08 | Price 0.12 | Shares 83,334
Sale 19 Dec 2024
Value US$883.94 | Price 0.19 | Shares 4,580
Buy 18 Dec 2024
Value US$4,681.76 | Price 0.21 | Shares 22,727
Buy 2 Dec 2024
Value US$2,355.53 | Price 0.21 | Shares 11,111
Buy 21 Nov 2024
Value US$4,240.00 | Price 0.21 | Shares 20,000
Buy 20 Nov 2024
Value US$15,816.93 | Price 0.19 | Shares 81,953
Buy 20 Nov 2024
Value US$16,915.00 | Price 0.20 | Shares 85,000
Buy 20 Nov 2024
Value US$11,000.13 | Price 0.18 | Shares 60,110
Buy 16 Sep 2024
Value US$1,515.00 | Price 0.30 | Shares 5,000
Buy 13 Sep 2024
Value US$6,160.00 | Price 0.31 | Shares 20,000
Buy 6 May 2024
Value US$25,000.24 | Price 0.41 | Shares 61,729
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-16 2025-06-13 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
14,818 +11.5%
146.17
US$3,170,511 		14,818 +11.5% 146.17 US$3,170,511
2025-06-13 2025-06-12 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
19,701 +48.3%
439.40
US$2,193,444 		19,701 +48.3% 439.40 US$2,193,444
2025-04-23 2025-04-11 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
3,963 +26.9%
214.10
US$1,982,091 		3,963 +26.9% 214.10 US$1,982,091
2025-04-23 2025-04-11 B Purchase
1.4
MITCHELL WILLIAM M
Non-Executive Director
196,851 +60.6%
0.03
US$5,000 		196,851 +60.6% 0.03 US$5,000
2025-04-23 2025-04-11 B Purchase
3.1
KELLNER TED D
Non-Executive Director
1,968,504 +196850.4%
0.03
US$50,000 		1,968,504 +196850.4% 0.03 US$50,000
2025-04-07 2025-04-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
41,000 +2.2%
0.06
US$2,583 		41,000 +2.2% 0.06 US$2,583
2025-04-04 2025-04-04 B Purchase
2.8
Rodino Peter W III

COO, Secretary, Gen. Counsel

Officer
500 +0.1%
0.09
US$44 		500 +0.1% 0.09 US$44
2025-03-06 2025-03-05 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
50,000 +2.8%
0.13
US$6,730 		50,000 +2.8% 0.13 US$6,730
2025-03-05 2025-03-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
44,000 +2.5%
0.12
US$5,060 		44,000 +2.5% 0.12 US$5,060
2025-03-04 2025-03-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
83,334 +5.0%
0.12
US$10,000 		83,334 +5.0% 0.12 US$10,000
2024-12-20 2024-12-19 S Sale
1.4
MITCHELL WILLIAM M
Non-Executive Director
4,580 -3.7%
0.19
US$884 		4,580 -3.7% 0.19 US$884
2024-12-19 2024-12-18 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
22,727 +1.4%
0.21
US$4,682 		22,727 +1.4% 0.21 US$4,682
2024-12-04 2024-12-02 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
11,111 +3.2%
0.21
US$2,356 		11,111 +3.2% 0.21 US$2,356
2025-01-21 2024-11-21 B Purchase Equels Thomas K

CEO & President

Executive Director
20,000 +1.2%
0.21
US$4,240 		20,000 +1.2% 0.21 US$4,240
2024-11-21 2024-11-20 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
81,953 +34.2%
0.19
US$15,817 		81,953 +34.2% 0.19 US$15,817
2024-11-21 2024-11-20 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
85,000 +5.5%
0.20
US$16,915 		85,000 +5.5% 0.20 US$16,915
2024-11-20 2024-11-20 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
60,110 +4.0%
0.18
US$11,000 		60,110 +4.0% 0.18 US$11,000
2024-09-17 2024-09-16 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
5,000 +0.3%
0.30
US$1,515 		5,000 +0.3% 0.30 US$1,515
2024-09-16 2024-09-13 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
20,000 +1.4%
0.31
US$6,160 		20,000 +1.4% 0.31 US$6,160
2024-05-07 2024-05-06 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
61,729 +8.6%
0.41
US$25,000 		61,729 +8.6% 0.41 US$25,000
Explore more

More insider trading research around AIM ImmunoTech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America